The Trillium Therapeutics Inc., TRIL has Loss (↓) on Friday, January 10, 2020 the stock price is settled at $2.75 after buying and selling hours while rehearsed a difference of -4.84 percent. The stock has a fifty two-week low of $1043.45 percent while its fifty two-weeks high are $-19.83 percent.
The total market cap for the stock is $77.11M while it has a PE ratio of 0. Active investor focuses on important indicators rehearsed a difference in session that includes where the Trillium Therapeutics Inc..
Each buying and selling session display one-of-a-kind actions and patterns about Trillium Therapeutics Inc. (TRIL) stock. Presently we watched the different factors that seen on close of last session. Toward the day’s end, it’s only a stock’s exhibition that issues.
Trillium Therapeutics Inc.’s overall performance:
The performance of the stock during the last 7.00 days was 118.25 percent,
during the last one-month price index is 759.38 percent while over the 3.00 months is 851.56 percent.
Its 6.00 months performance has been 657.37 percent while for the beyond 52.00 weeks is 38.89 percent.
We have additionally seen that the stock is exchanging 387.63 percent away from the 50-day MA and 510.64 percent of the 20-day MA.
How much shares are traded?
The stock traded hands with 30004269 numbers of shares contrast to its normal every day volume of 2.08M shares.
What amount of stock is unpredictable?
Beta factor was seen at 0. Beta estimates the hazard of the security. High beta >1 means implies higher dangerous and low beta <1 shows low peril. The stock remained 50.02 percent erratic for the ongoing week and 31.74 percent for the last month.
Trillium Therapeutics Inc. has a P/S and P/B values of 0 and 31.98 respectively. Its P/Cash valued at 0. The TRIL has PEG of 0. Technical indicators do not lead us to assume the stock will see more gains anytime soon.
Analyst’s mean target amount for the company is 11.02 while analysts mean suggestion is 1.5.